相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma
Armando Santoro et al.
BLOOD ADVANCES (2020)
The role of transplantation in Hodgkin lymphoma
Alessandro Broccoli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study
Armando Santoro et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma
Ryan D. Gentzler et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant
Sally Arai et al.
LEUKEMIA & LYMPHOMA (2013)
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy
Raynier Devillier et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma
Alison J. Moskowitz et al.
BLOOD (2010)
High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging
Craig H. Moskowitz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Dose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma
Andreas Josting et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Ifosfamide, gemcitabine, and vinorelbine: a now induction regimen for refractory and relapsed Hodgkin's lymphoma
Armando Santoro et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse
A Sureda et al.
ANNALS OF ONCOLOGY (2005)
Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group
T Baetz et al.
ANNALS OF ONCOLOGY (2003)
Time-intensified dexamethasone/cisplatin/cytarabine:: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease
A Josting et al.
ANNALS OF ONCOLOGY (2002)
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease:: a randomised trial
N Schmitz et al.
LANCET (2002)
分享论文
